Increased toll-like receptor 9 expression in cervical neoplasia
about
Mucins and toll-like receptors: kith and kin in infection and cancerIL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy ResistanceEffect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligationToll-like receptor transcriptome in the HPV-positive cervical cancer microenvironmentDistinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patientsOverexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells.TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells.TLR signaling by tumor and immune cells: a double-edged sword.Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection.Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.Toll-like receptors and genital tract infection.Toll-like receptor signaling pathways--therapeutic opportunities.The application of Toll like receptors for cancer therapy.Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptors in human papillomavirus infection.Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro.Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiationToll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.Toll-Like Receptor 9 Agonists for Cancer Therapy.
P2860
Q26830597-6305592A-7A5D-431D-BDE7-C737A328CFC5Q26866390-7F774D09-FA29-4891-9986-83C5DA618356Q31170767-9B911D52-D3D7-49BF-A1AC-01666CD45A53Q33579661-6681BC5D-19B2-4FCB-93A4-C1457F340F47Q33653031-39E8B147-9AD0-4D89-B167-07BE25E7F0FBQ33801246-9D3A92D7-69BC-4F6C-BB02-44F84B83B17CQ34052237-30C61268-51A7-41D1-863F-DCE0F9CD45AAQ34342371-3BAF84D7-F5B0-442B-BA4D-CDB26A89B82BQ35235996-CE4A22F9-2430-44F4-B0D7-A58E0B35545EQ35599302-C8D7E314-8354-4420-8E97-36E3F4A9CDABQ36710952-AD93D70E-4A39-4E21-A628-1EB5BA3AE1A0Q37051027-DAB30ED2-4C7F-4484-BA23-B648FE2A75FBQ37111066-06741E01-02DF-4397-A47C-88CF510B04B2Q37198685-807FCA9A-C74C-4EF6-85D3-C67DB9AC53C1Q37373357-3BB713D5-50D8-4E01-85A2-38F6F12EEA7AQ37705702-4ECC67D3-BC62-407B-B8E7-42F95CC7DAC6Q37803540-746B9BB1-7757-482C-9B0C-33C550D36362Q37808111-980E7FC3-AE07-41AA-AE04-05DB008C4BC3Q38039958-3B6F101C-14EB-471C-9633-231E527DBA19Q38084160-2BA22CE7-949F-4A16-B10B-D44020801CACQ38727874-29725638-1A1E-4F7E-B734-259CDE146BBFQ39256403-C5E62D4D-4028-4CC9-A9AD-AE3B853DDDEAQ39339457-DF87ACD7-6120-460C-BC1B-01B7B25EACB6Q39493570-C42E45B7-F96A-42C6-9CDD-95FE401C3729Q39809527-DAD011C5-87A4-499A-924F-9A07F54D2CFEQ40088761-0C999436-C44B-4586-9DCC-FB3CC50D1457Q40220618-1680D9D7-CADC-4EA1-A979-69DA257E8079Q41713855-8D079C14-5F1A-4466-825D-DA2752BBAF45Q42493565-088F7B71-6A70-4879-9CAE-79B605136D09Q50863800-3A1BE94D-3605-4322-883C-0CEC7E369622
P2860
Increased toll-like receptor 9 expression in cervical neoplasia
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased toll-like receptor 9 expression in cervical neoplasia
@ast
Increased toll-like receptor 9 expression in cervical neoplasia
@en
Increased toll-like receptor 9 expression in cervical neoplasia
@nl
type
label
Increased toll-like receptor 9 expression in cervical neoplasia
@ast
Increased toll-like receptor 9 expression in cervical neoplasia
@en
Increased toll-like receptor 9 expression in cervical neoplasia
@nl
prefLabel
Increased toll-like receptor 9 expression in cervical neoplasia
@ast
Increased toll-like receptor 9 expression in cervical neoplasia
@en
Increased toll-like receptor 9 expression in cervical neoplasia
@nl
P2093
P2860
P356
P1476
Increased toll-like receptor 9 expression in cervical neoplasia
@en
P2093
Byoung-Gie Kim
Chel Hun Choi
Duk-Soo Bae
Eun Sung Seo
Jeong-Won Lee
Jung-Joo Choi
Mi Jin Kim
Sang Yong Song
Tae-Joong Kim
Woo Young Kim
P2860
P356
10.1002/MC.20325
P407
P577
2007-11-01T00:00:00Z